Deals & Cases
Polsinelli Advises SpyGlass Pharma on Intellectual Property Matters in Initial Public Offering
Firm Highlights
Slide 1 of 6
- EventHome Care Industry Update - September 2026Please join industry leaders for a high-impact briefing on the latest advocacy, regulatory and legal developments shaping the future of home-based care.Read more
- NewsPolsinelli Represents LiveWell in Acquisition of Michigan Community VNAPolsinelli recently represented LiveWell Partners (LiveWell), a leading home care provider with a focus on building clinical teams that deliver top-decile clinical outcomes and patient scores, in their acquisition of Michigan Community VNA, a home health, hospice, and wellness agency committed to enhancing quality of life through extraordinary care and a collaborative clinical treatment approach.Read more
- Blog
Federal Contractor Affirmative Action Shift: OFCCP Ends Disability Self-ID and Utilization RequirementsRead more - NewsPolsinelli Surpasses $2 Billion in C-PACE FinancingsPolsinelli has surpassed $2 billion in commercial property assessed clean energy (C-PACE) financing originations on behalf of its clients, reaching the milestone less than a year after announcing that the firm had advised clients on more than $1 billion in C-PACE transactions nationwide.Read more
- PublicationPatent Eligibility Wars: A New Hope at the PTABPatent applicants challenging subject-matter eligibility rejections under 35 U.S.C. § 101 are seeing improved results at the PTAB.Read more
- EventAlgorithm Under Review: APA Challenges to Government Use of AIAs federal agencies like HHS and the FDA increasingly incorporate artificial intelligence into regulatory decision-making and enforcement, courts are beginning to confront how traditional Administrative Procedure Act (APA) principles apply to AI-driven agency actions.Read more